Bendectin (Debendox) as a risk factor for pyloric stenosis
- 1 December 1982
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 144 (8) , 919-924
- https://doi.org/10.1016/0002-9378(82)90185-5
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Bendectin and fetal developmentAmerican Journal of Obstetrics and Gynecology, 1982
- Birth Defects Related to Bendectin Use in PregnancyJAMA, 1981
- Is Bendectin a Teratogen?Published by American Medical Association (AMA) ,1981
- Is Bendectin a teratogen?JAMA, 1981
- Debendox and congenital malformations in Northern Ireland.BMJ, 1980
- Unprecedented rise in incidence of infantile hypertrophic pyloric stenosis.BMJ, 1980
- EXOGENOUS HORMONES AND OTHER DRUG EXPOSURES OF CHILDREN WITH CONGENITAL HEART DISEASE1American Journal of Epidemiology, 1979
- Antenatal exposure to doxylamine succinate and dicyclomine hydrochloride (Bendectin) in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient scoreAmerican Journal of Obstetrics and Gynecology, 1977
- An evaluation of the teratogenicity of certain antinauseant drugsAmerican Journal of Obstetrics and Gynecology, 1976
- Prospective versus retrospective approach in the search for environmental causes of malformations.American Journal of Public Health and the Nations Health, 1967